AxoGen Inc (AXGN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:AxoGen Inc (AXGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011433
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions for peripheral nerve injuries. The company offers AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products. It also offers clinical research studies in understanding and outcome of peripheral nerve regeneration and reconstruction projects. AxoGen’s clinical research programs comprise the CHANGE study, the RANGER study, and the RECON study programs. The company sells its products through a network of distributors in the US and abroad. AxoGen is headquartered in Alachua, Florida, the US.

AxoGen Inc (AXGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AxoGen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AxoGen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AxoGen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AxoGen Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
AxoGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
AxoGen Inc, Medical Equipment, Deal Details 10
Venture Financing 10
AxoGen Secures An Additional US$3 Million In Financing 10
Equity Offering 11
AxoGen Raises USD41 Million in Public Offering of Shares 11
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 13
AxoGen Raises USD20 Million in Public Offering of Shares 14
AxoGen Raises USD17.5 Million in Private Placement of Shares 16
AxoGen Raises USD15 Million in Public Offering of Shares 18
AxoGen Completes Underwriters’ Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For US$18.6 Million 19
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 20
Acquisition 21
LecTec Completes Acquisition Of AxoGen In Reverse Acquisition 21
AxoGen Inc – Key Competitors 22
AxoGen Inc – Key Employees 23
AxoGen Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Nov 01, 2017: AxoGen Reports 2017 Third Quarter Financial Results 25
Aug 02, 2017: AxoGen Reports 2017 Second Quarter Financial Results 26
May 04, 2017: AxoGen Reports 2017 First Quarter Financial Results 27
Feb 22, 2017: AxoGen Reports 2016 Fourth Quarter and Full Year Financial Results 28
Jan 09, 2017: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue 30
Nov 02, 2016: AxoGen Reports Financial Results for Third Quarter 2016 31
Aug 03, 2016: AxoGen Reports Financial Results for Second Quarter 2016 32
May 04, 2016: AxoGen First Quarter Revenue Increases 64% Over Prior Year to $8.1 Million 33
Corporate Communications 34
Oct 18, 2017: AxoGen Receives David J. Gury Company of the Year Award from BioFlorida 34
Jul 17, 2017: AxoGen Appoints Jon Gingrich Chief Commercial Officer 35
Jan 05, 2017: AxoGen Appoints Ivica Ducic Medical Director 36
Sep 19, 2016: AxoGen Appoints Amy Wendell to Board of Directors 37
Product News 38
Nov 20, 2017: AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day 38
Sep 12, 2016: AxoGen to Participate at the American Association of Oral and Maxillofacial Surgeons 98th Annual Meeting 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
AxoGen Inc, Medical Equipment, Key Facts, 2016 2
AxoGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
AxoGen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AxoGen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AxoGen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AxoGen Inc, Deals By Market, 2011 to YTD 2017 8
AxoGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
AxoGen Secures An Additional US$3 Million In Financing 10
AxoGen Raises USD41 Million in Public Offering of Shares 11
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 13
AxoGen Raises USD20 Million in Public Offering of Shares 14
AxoGen Raises USD17.5 Million in Private Placement of Shares 16
AxoGen Raises USD15 Million in Public Offering of Shares 18
AxoGen Completes Underwriters’ Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For US$18.6 Million 19
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 20
LecTec Completes Acquisition Of AxoGen In Reverse Acquisition 21
AxoGen Inc, Key Competitors 22
AxoGen Inc, Key Employees 23
AxoGen Inc, Other Locations 24
AxoGen Inc, Subsidiaries 24

★海外企業調査レポート[AxoGen Inc (AXGN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fraser & Neave Holdings Bhd:戦略・SWOT・企業財務分析
    Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Petro Welt Technologies AG (O2C):企業の財務・戦略的SWOT分析
    Petro Welt Technologies AG (O2C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Veolia Environnement SA (VIE):電力:M&Aディール及び事業提携情報
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …
  • Generali Deutschland AG:企業の戦略・SWOT・財務情報
    Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report Summary Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dean Foods Co:戦略・SWOT・企業財務分析
    Dean Foods Co - Strategy, SWOT and Corporate Finance Report Summary Dean Foods Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Abeome Corp-製薬・医療分野:企業M&A・提携分析
    Summary Abeome Corp (Abeome) is a biotechnology company that discovers diagnostic monoclonal antibodies and therapeutic antibodies. The company's pipeline components include PCSK9 to treat hypercholesterolemia; IL-17A to treat psoriasis and inflammation diseases, IL-17F to treat autoimmune diseases, …
  • Theravasc Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Theravasc Inc (Theravasc) is a pharmaceutical company that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product includes TV1001SR, a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases a …
  • Nativis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nativis Inc (Nativis) is a clinical stage bio-electronics company. The company provides portfolio of pipeline candidates which are under development for various therapeutic areas such as recurrent glioblastoma, brain metastisis, pain, rheumatoid arthritis, lung cancer and melanoma, among oth …
  • Garvan Institute of Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary Garvan Institute of Medical Research (Garvan Institute) is a biomedical institute that offers research services. The institute conducts research in the fields of cancer, diabetes and obesity, Alzheimer’s and Parkinson’s disease, asthma, rheumatoid arthritis, osteoporosis, arthritis and pitui …
  • Sigla, S.A.:企業の戦略的SWOT分析
    Sigla, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Citation Oil & Gas Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Citation Oil & Gas Corp (Citation) is an oil and gas exploration company that acquires, produces, and develops oil and gas properties. The company's products include natural gas, NGL, crude oil, and coalbed methane gas. It conducts asset development program for production and recoverable res …
  • Olin Corp (OLN):企業の財務・戦略的SWOT分析
    Olin Corp (OLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Shire Plc (SHP)-医療機器分野:企業M&A・提携分析
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Virginia Electric and Power Company:電力:M&Aディール及び事業提携情報
    Summary Virginia Electric and Power Company (Virginia Power), formerly Virginia Public Service Corporation, is a regulated energy utility that generates, transmits, and distributes electricity. It generates electricity from gas, nuclear, oil, coal, renewable, and biomass sources. The company also pr …
  • The Tata Power Company Limited:企業の戦略・SWOT・財務分析
    The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Amgen, Inc.:企業のM&A・事業提携・投資動向
    Amgen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amgen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • QRxPharma Ltd:企業の戦略的SWOT分析
    QRxPharma Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Bukwang Pharm Co Ltd (003000):製薬・医療:M&Aディール及び事業提携情報
    Summary Bukwang Pharm Co Ltd (Bukwang Pharmaceutical) is a pharmaceutical company that develops new drugs and pharmaceutical products. The company’s products portfolio includes dexid, thioctacid, levovir, legalon, Orfil, azeptin, lonasen, ixel, and asima, among others. Its pipeline products comprise …
  • Asure Software, Inc. (ASUR):企業の財務・戦略的SWOT分析
    Asure Software, Inc. (ASUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆